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Monitor pcptidc (CCK-releasing peptide) mRNA increased on the administration of CCK in rat pancreas and the AR4-2J pancreatic ell line. 
Subcutaneous injection of CCK into rats at 8 h intervals increased the level of monitor pcptidc mRNA in the pancreas. Concomitant injection 
of CCK antagonist CR-1409 strongly decreased it. The monitor pcptidc mRNA was also increased by CCK in AR4-2J cells and was decreased 
by the antagonist. These findings suggest that the plasma CCK induced by prolonged intake of a high protein diet may be responsible for the 
adaplativc increase in the monitor peptide as well as exocrine proteases in the pancreas. 
Monitor peptide; mRNA level: Cholccystokinin (CCti): CCK antagonist; Pancreas; AR4.2J 
I. INTRODUCTION 
The monitor peptide (CC&releasing peptide), origi- 
nally found in the bile-pancreatic juice of rats [I], is an 
essential luminal factor for pancreatic nayme secretion 
via CCK-release in rats [2,3]. The infusion cf the moni- 
tor peptide into the lumen induces hypers.ecretion of
CCK and a subsequent increase in the level of pancre- 
atic enzyme secretion [2]. 
Previously, we reported that both the concentration 
in zymogen granules and mRNA level of the monitor 
peptide as well as pancreatic proteases in the rat pan- 
creas increased in response to prolonged high protein 
intake [4]. Although the mechanism underlying the in- 
crease in the monitor peptide caused by high protein 
intake remains unclear, it is important o elucidate the 
mechanisms underlying the adaptative increase in exo- 
crine proteases due to cominuous high protein intake. 
There is growing evidence that CCK is involved in the 
adaptative increase in pancreatic proteases in response 
to prolonged high protein intake [5], therefore, CCK 
may also induce an increase in the monitor peptide level 
in the pancreas. 
The stimulatory effect of CCK on the monitor pep- 
tide level in the pancreas was examined. Repeated 
subcutaneous injection of CCK increased the monitor 
peptide mRNA level in the rat pancreas and it was 
suppressed by the CC&antagonist, CR-1409. To dem- 
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onstrate the direct effect on pancreatic acinar cells, 
AR4-2J, a pancreatic acinar cell line, was used. 
2. MATERIALS AND METHODS 
3.1. In ~~ivo rxpcrimerft 
Male Wistar rats (Oriental Bioservice, Kyoto): each weighing I80- 
200 g, rel:eivcd subcutaneous injections of 1 ,ugIkg body weight of 
CCK-5 (Peptide Institute Inc.. Osaka) dissolved in saline containing 
12% (w/v) hydrolyzed gelatin (Sigma) at 8 h intervals for 5 days. A 
specific CCK receptor antagonist, CR-1409, was injected at a dose of 
5 mg/kg subcutaneously 30 min before each CCK injection. Tlie CR- 
1409 was provided by Rotta Research Laboratory (Italy). Pancreases 
were sampled bcforc CCK injection (0 II), and then 4, IO, 24, 48. 72 
and 120 h after starting the CCK injections. Total RNA was extracted 
by the AGPC method [cl], denatured and passed through nylon filters. 
The mRNA was quantified by means of slot-blot hybridization. JzP 
randomly primed monitor peptidc cDNA and a ‘zP-5’.cnd-labelcd 
oligonuctcotidc specific to the monitor pcptide were used as probes [4]. 
The rat chymotrypsinopen 13 and amylase mRNA levels were also 
determined using the corresponding cDNAs, which were closed in our 
laboratory, as probe!; [7.8]. The conditions for hybridization and the 
determination of bound radioactivity with a densitometer were the 
same as given previously [4]. The profile of the increase in the monitor 
peptide concentration in zymogen granules was confirmed to be the 
sdrne as that of mRNA in the pancreas [4], 
2.2. I/t vitro esperittfcnr 
The AR4-21 cell line [9] was purchased from Dainippon Seiyaku 
(Osaka). The cells were maintained at 37OC under a 5% C+_/95% air 
atmosphere in Dulbccco’s modified Eagle’s medium containing 10% 
(v/v) fetal calf serum. To determine whether or not the cells express 
the monitor peptidc mRNA, poly(A)+ RNA was prepared and ana- 
lyzed by Northern blotling. For quanlitalivc determination of llie 
change in the mRNA level of the monitor pcptide caused by CCK, 
AR4-2J cells were seeded into 35 mm dishes at an approximate density 
of 3-4 x 10?cm2. Five days after plating, the cells were about 80% 
confluent, and the culture medium was replaced by medium (0 h) 
containing CCK-8 (IO nM) or CCK-8 plus CR-1409 (IOOpM), each 
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dissolved in PBS, and was changed daily. Total RNA was cxtractcd 
from the cultured cells before thcnddilion of CCK (0 h), and then 12. 
24. 48 und 72 h after tbc addition or CCK. mRNA was quantilicd 
using the mvcrsc rranscriplioll-polymfrasc chuin reaction (RT-PCR) 
method [IO]. Onepg of total RNA wets rcvcrsc trunscribsd to obtain 
cDNA with a downstream primer specilic to the monitor pcptide. 
PCR was pcrformcd with 2 out of the lOti ofthc cDNA iis a tcmplatc 
with Heat-TUFF DNA polymerasc (Clan~ucb, USA). A combination 
of upstream and downstream primers was used to detect he monitor 
peptide mRNA. In preliminary cxpcrimcnts. various PCR conditions 
were examined with different amounts or 1014 RNA to find the con- 
ditions with which diffcrcnt amounts of monitor pcptidu mRNA pro- 
portionally atkct the yield or the PCR product. The following condi- 
tions were adapted in the present study: 22 cycles pcrformcd with a 
PROGRAM TEMP CONTROL SYSTEM PC-700 (ASTEC. 
Fukuoka) :u ‘:trlcC for I min. 60°C Ibr? min. 72°C far 3 min and 72°C 
for 6 nrin 81 the end with ItJ pm01 afcach pair or primers and 1.5 IIIM 
MgCI,. The specificity of theamplitication was verified by showing the 
size fragments of PCR products alicr enzymatic diycetion ;md by 
Southern blatting with the monitor pcptidc or pancreatic sccrctory 
trypsin inhibitor spccilic oliganuclcatidcs ;IS probes [4]. Tbc PCR 
products were quantilied by DNA slot-blot hybridization. 
3. RESULTSANDDISCUSSION 
CCK exerts a trophic action on I!X pancrcns [I I]. In 
the present in vivo study, CCK induced marked pancre- 
atic growth, wllich was suppressed by tile CCK antago- 
nist, CR-1409 (data not shown). Therefore, tile result of 
CCK administration to rats in the present study was 
similar to that reported previously [I I]. 
The CCK-induced change in tile monitor pcptide 
mRNA in the rat pancreas was determined by slot-blot 
hybridization. As shown in Fig. I, the monitor peptide 
mRNA level in rats, which was determined using the 
monitor peptide cDNA as a probe, increased after 24 
h CCK administration and reached a maxima! level 
after 72 h. An identical result was obtained using a 
monitor peptide specific oligonucleotide as a hybridiza- 
tion probe (data not shown). The chymotrypsinogcn B
and amylasc mRNAs were determined as reliable indi- 
cators of the pancreatic response to CCK. An increase 
in chymotrypsinogen B mRNA was observed at 120 h 
after starting the CCK injections. Amylase mRNA did 
not change throughout he experiment. The results ob- 
tained with tile two pancreatic enzymes were compatible 
with those obtained previously [5]. As Fig. 2 shows, 
concomitant injection of CR-1409 wit!1 CCK blocked 
the increase in the monitor peptide mRNA significantly, 
which indicates tlzat he increase in t!?e monitor peptide 
mRNA in the rats was caused by the exogenous injec- 
tion of CCK. 
The results obtained in an experiment involving the 
AR4-2J cell line were the same as those obtained in the 
in vivo experiment. The AR4-2J cell line was established 
from an azaserine-induced rat pancreatic adenocar- 
cinema 191. This ccl! line has been reported to express 
cxocrine enzymes [12]. Recently, Estiva! et al. [I 31 re- 
ported tlntt 10 nM caerulein, which is an analoguc of 
CCK, increased tile chymotrypsinogen B mRNA in 
AR4-2J cells. We first examined whether or not tllc 
Time (h) 
Fig. I. Effect of CCK on the monitor pcptidc. chynotrypsinogcn B 
and amylasr mRNA levels in rag pantreas. Pancreatic mRNA was 
determined in saline (containing hydrolyzed g&tin) (0) and CCK- 
trelited (OJ animals by slot-blot hybridization with the corresponding 
cDNAs as probes. V&W, obtained rNc’rc expressed as pereentagcs of
tlrasc of0 h. Data shown represent means 2 SD. for &5 animals for 
cxh time paint. Significant diffcrcncc from saline-treated nnimuls: 
‘PC 0.05; “P c 0.01; “‘P c O.oQl. 
monitor peptide was expressed in this cell line. As 
shown in Fig. 3. a signal was detected on Northern 
blotting with the monitor peptide cDNA as a probe. 
However, as reported previously [4], the cDNA prube 
could not distinguish the monitor peptide mRNA from 
that of the pancreatic secretory trypsin inhibitor be- 
cause of their big!? nucleotidc sequence homology. No 
hybridization signal wit!1 tile monitor peptide specific 
oligonuclcotide probe was observed for the cell line. 
Tllen. we performed RT.-PCR with tile monitor peptide 
specific primers: downstream primer, SCTTGCTAA- 
ACATTATCGTAGCCC3’; and upstream primer, 
5’CCTAATTGCCCTAAGC.4AATTATG3’. The RT- 
PCR product yielded hybridized with the monitor pep- 
tide specific o!igonuc!eotide (Fig. 3), but not with the 
Mon Thor peptkto Chymoirypsinogen Atnylase 
Fig. 2. Effect of a CCK antogonisl (CR-141i9) on the monitor pptide. 
chymoxypsinogcn B and amylasc mRNA levels in rat pancreas. The 
mRNA lcvcls in the pancreas at 120 h alicr starting the CCK injections 
arc cxpresscd as pcrccntqcs of that in the saline-treated animals. Data 
shown rcprcsent mcxts 4 SD. for 4-5 animals. Significant diffcrcnec 
from CCK-treated animals: ‘P < 0.05. 
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Fig. 3, (A) Northern blot analysis of the monitor peptide mRNA in 
AR4-2 cells, Daly(A)’ RNA (20 pg) was hybridized with [“‘P]cDNA 
of the monitor peptide (lane I) or with a Wlnbcled monitor pcptide 
specitic oligonucleotidc [4] (lane 2). The size of the monitor pptide 
mRNA is indicated. (B) Southern blot analysis of PCR products: lane 
1, cDNA amplified by PCR from the monitor pcptide cDNA clone [S] 
as a template; lane 2, cDNA amplified by RT-PCR from totul RNA 
of the AR42J cells. The specific primers for the monitor peptide 
described in the text were used for amplification. The amplified DNAs 
were hybridized with the “2PBmonitor peptide specific oligonucleotide 
141, The size of the amplilicd cDNA of the monitor peptide is indicated 
on the left. (C)The linear relationship between the amount ofapplied 
RNA (0.375, 0.75 and 1.5 ,~g) and the corresponding RT.PCR prod- 
ucts after various PCR cycles. The RT-PCR products were pusscd 
through a nylon tiller and then hybridized with the J2P.monitor pep. 
tide specific oligonuclcotide [4]. Bound radioactivity was determined 
by scanning the autoradiograph with a densitomer. Values are ex- 
pressed as pcrcentagcs of the density of I S,uugof RNA after 33 cycles. 
pancreatic secretory trypsin inhibitor specific oligonu- 
cleotide [4], In addition, 88 and 112 bp fragments, which 
were expected from the monitor peptide cDNA se- 
quence, were observed by Bsnrl digestion of the RT- 
PCR products. EcoT221, which digests the pancreatic 
secretory trypsin inhibitor cDNA but not the monitor 
peptide cDNA, did not digest the RT-PCR products. 
This is the first report of cultured cells expressing the 
monitor peptide mRNA. A linear relationship was re- 
vealed between the amount of applied RNA and the 
corresponding PCR product up to 25 cycles (Fig. 3). 
Fig. 4 shows that the addition of CCK to the medium 
to a final concentration of 10 nM led to an increase in 
the monitor peptide mRNA level. The increasing profile 
in the cell study was similar to that observed in an in 
vivo experiment. In the presence of CR-1409 in the 
medium, the monitor peptide mRNA was not increased 
by CCK. These results indicate that exogenous CCK 
causes an increase in the monitor peptide mRNA level 
in both rats and a cell culture, which suggests that CCK 
is responsible for the adaptative increase in the monitor 
peptide in the pancreas during prolonged high protein 
diet intake. 
Time (h1 
Fig. 4. Effects of CCK and a CCK antagonist on the monitor peptide 
mRNA level in AR4-2J cells. mRNAs were amplified from PBS- (01, 
CCK- (0) and CCK plus antagonist-treated cells (I) by means of 
kT-PCR and the resulting PCR products were quantified by slot.blot 
hybridization. Values are expressed as percentages of thut of0 h. Data 
rcpreacnt means P S.D. for 3-6 separate dishes. Significant difference 
from PBS-treated ishes: ‘P c 0.05. 
In conclusion, we propose a cycle in which the plasma 
CCK increases the monitor peptide in the pancreas, 
which in turn induces a high plasma CCK level. Such 
a cycle may be involved in the adaptative increase in the 
pancreatic exocrine proteases on prolonged high pro- 
tein intake. This cycle can slow down when the pancre- 
atic proteases reach a level sufficient for protein diges- 
tion, because the monitor peptide in the lumen is easily 
digested by largs amounts of proteases. 
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